ImmunoPrecise Antibodies

ImmunoPrecise Antibodies

Biotechnology
ImmunoPrecise Antibodies Ltd is a techbio company that leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies. The Company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies and are known for solving very complex industry challenges. IPA has several subsidiaries in North America and Europe.

$67.7M

Market Cap • 7/11/2025

1983

(42 years)

Founded

2010

(15 years ago)

IPO

NASDAQ

Listing Exchange

Flag of US

Austin

Headquarters • Texas